Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAALAD2 | Q9Y3Q0 | 4/20 | 0.45 |
| ▸ | GGH | Q92820 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | ADAMTS4 | O75173 | 2/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
| ▸ | MMP8 | P22894 | 1/20 | 0.43 |
| ▸ | MMP13 | P45452 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.40 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4627986 | 0.91 | NAALAD2 (0.51) | NAALAD2GGHGAAADAMTS4MMP9 | |
| SCHEMBL4627982 | 0.91 | NAALAD2 (0.51) | NAALAD2GGHGAAADAMTS4MMP9 | |
| SCHEMBL13726857 | 0.91 | NAALAD2 (0.51) | NAALAD2GGHGAAADAMTS4MMP9 | |
| SCHEMBL30278728 | 0.84 | LMNA (0.40) | LMNAHSD17B10CHRM2CHRM4CHRM1 | |
| SCHEMBL29964734 | 0.83 | KIF11 (0.50) | NAALAD2GGHADAMTS4MMP9ADAMTS5 | |
| SCHEMBL7168982 | 0.82 | MME (0.45) | LMNA | |
| SCHEMBL7157827 | 0.80 | MMP2 (0.53) | NAALAD2GGHGAAMMP9MMP8 | |
| SCHEMBL28288740 | 0.80 | ADAMTS4 (0.43) | NAALAD2GGHGAAADAMTS4ADAMTS5 | |
| SCHEMBL5495801 | 0.80 | KMT2A (0.52) | NAALAD2GGHGAAMMP9MMP8 | |
| SCHEMBL3607588 | 0.80 | MME (0.47) | HSD17B10CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8193156-B1 | Dipeptides incorporating selenoamino acids with enhanced bioavailability—synthesis, pharmaceutical and cosmeceutical applications thereof | SAMI LABS LTD | 2012-06-05 | — | — | US | disclosed |
| US-8003614-B2 | Dipeptides incorporating selenoamino acids with enhanced bioavailability—synthesis, pharmaceutical and cosmeceutical applications thereof | SAMI LABS LTD (US) | 2011-08-23 | — | — | US | disclosed |
| US-20080026017-A1 | Novel Dipeptides incorporating selenoamino acids with enhanced bioavailability- Synthesis, pharmaceutical and cosmeceutical applications thereof | SAMI LABS LIMITED (IN) | 2008-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080026017-A1 | Novel Dipeptides incorporating selenoamino acids with enhanced bioavailability- Synthesis, pharmaceutical and cosmeceutical applications thereof | SCLY, CYP2R1, SPR | NAALAD2 785/4885GGH 94/4885GAA 3682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.